Trial Profile
A retrospective, single-center cohort study evaluating treatment Persistence for Infliximab Versus Adalimumab in patients with Crohn's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Apr 2018 New trial record